← Open Payments lookup

KEISHA HINDS: Open Payments

NPI 1750784419 · BRANDYWINE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,451 in 109 payments from 38 companies in 2025. Trend: 2023 $3,126 · 2024 $3,035 · 2025 $3,451

Food & beverage: $2,369Long term medical supply or device loan: $1,082
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation22$1,298
Merck Sharp & Dohme LLC9$205
AstraZeneca Pharmaceuticals LP6$178
BeOne Medicines USA, Inc.5$145
PFIZER INC.6$134
Janssen Biotech, Inc.5$121
Genentech USA, Inc.4$102
PharmaEssentia USA Corporation3$98
Incyte Corporation4$85
Stemline Therapeutics Inc.3$83

Products named: KISQALI, KEYTRUDA, BESREMI, Venclexta, BRUKINSA, Orserdu, CABOMETYX, Enhertu.

Industry payments across MD — which companies pay providers there.